Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.

Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G.

J Allergy Clin Immunol. 2010 Mar;125(3):569-74, 574.e1-574.e7. doi: 10.1016/j.jaci.2009.10.060. Epub 2010 Feb 7. Review.

PMID:
20144472
2.

Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.

Phillips JF, Lockey RF, Fox RW, Ledford DK, Glaum MC.

Allergy Asthma Proc. 2011 Jul-Aug;32(4):288-94. doi: 10.2500/aap.2011.32.3446.

PMID:
21781404
3.

Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.

Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI.

Ann Allergy Asthma Immunol. 2011 Nov;107(5):426-431.e1. doi: 10.1016/j.anai.2011.05.020. Epub 2011 Jun 17.

PMID:
22018614
4.

[Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].

Li MR, Wang XN, Jiang HD, Wang QY, Li YC, Lin J, Jin K, Zhang HL, Li CC.

Zhonghua Er Ke Za Zhi. 2012 Oct;50(10):726-31. Chinese.

PMID:
23302557
5.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, Paul MM, Sugerman RW, Lee JO, Lester MR, Mendelson LM, Nacshon L, Levy MB, Goldberg MR, Elizur A.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):91-6. doi: 10.1016/j.jaip.2013.10.001.

PMID:
24565775
6.

Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.

Bahceci Erdem S, Nacaroglu HT, Karaman S, Unsal Karkıner CS, Gunay I, Dogan D, Asilsoy S, Altınoz S, Can D.

Int J Pediatr Otorhinolaryngol. 2016 May;84:55-60. doi: 10.1016/j.ijporl.2016.02.032. Epub 2016 Mar 5.

PMID:
27063754
7.

The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.

Adamic K, Zidarn M, Bajrovic N, Erzen R, Kopac P, Music E.

Wien Klin Wochenschr. 2009;121(9-10):357-60. doi: 10.1007/s00508-009-1172-0.

PMID:
19562302
8.

AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.

Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):161-7. doi: 10.1016/j.jaip.2014.01.004.

PMID:
24607043
9.

Immunotherapy safety: what have we learned from surveillance surveys?

Kannan JA, Epstein TG.

Curr Allergy Asthma Rep. 2013 Aug;13(4):381-8. doi: 10.1007/s11882-013-0353-0. Review.

PMID:
23636820
10.

The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.

Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM.

Int Forum Allergy Rhinol. 2015 Feb;5(2):149-56. doi: 10.1002/alr.21443. Epub 2014 Dec 4.

11.

Incidence and characteristics of biphasic reactions after allergen immunotherapy.

Scranton SE, Gonzalez EG, Waibel KH.

J Allergy Clin Immunol. 2009 Feb;123(2):493-8. doi: 10.1016/j.jaci.2008.10.026. Epub 2008 Dec 6.

PMID:
19064282
12.

Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.

Kartal O, Gulec M, Caliskaner Z, Musabak U, Sener O.

Immunopharmacol Immunotoxicol. 2015 Jun;37(3):280-6. doi: 10.3109/08923973.2015.1027918. Epub 2015 Apr 10.

PMID:
25858053
13.

Safety of sublingual grass pollen immunotherapy after anaphylaxis.

Nichani JR, de Carpentier J.

J Laryngol Otol. 2009 Jun;123(6):683-4. doi: 10.1017/S0022215108002879. Epub 2008 May 23.

PMID:
18501039
14.

Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.

Quiralte J, Justicia JL, Cardona V, Dávila I, Moreno E, Ruiz B, García MA.

Immunotherapy. 2013 Dec;5(12):1295-303. doi: 10.2217/imt.13.133.

PMID:
24283840
15.

AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?

Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI.

Ann Allergy Asthma Immunol. 2013 Apr;110(4):274-8, 278.e1. doi: 10.1016/j.anai.2013.01.015. Epub 2013 Feb 21.

PMID:
23535092
16.

[New administration routes for immunotherapy].

Martorell Aragonés A.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):93-102. Review. Spanish.

PMID:
10867377
17.

Systemic reactions to immunotherapy.

Matloff SM, Bailit IW, Parks P, Madden N, Greineder DK.

Allergy Proc. 1993 Sep-Oct;14(5):347-50.

PMID:
8288117
18.

Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study.

La Shell MS, Calabria CW, Quinn JM.

J Allergy Clin Immunol. 2010 Jun;125(6):1294-9. doi: 10.1016/j.jaci.2010.02.041. Epub 2010 May 7.

PMID:
20451988
19.

Anaphylaxis: acute treatment and management.

Ring J, Grosber M, Möhrenschlager M, Brockow K.

Chem Immunol Allergy. 2010;95:201-10. doi: 10.1159/000315953. Epub 2010 Jun 1. Review.

PMID:
20519892
20.

Systemic reactions to subcutaneous allergen immunotherapy.

Bernstein DI, Epstein T.

Immunol Allergy Clin North Am. 2011 May;31(2):241-9, viii-ix. doi: 10.1016/j.iac.2011.02.007. Review.

PMID:
21530817

Supplemental Content

Support Center